FDA Approves Injectable Medication to Be Used as HIV Prevention Drug

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

Health activists pressure Gilead to drop price of anti-HIV jab

Accelerating global access to affordable injectable lenacapavir should be top priority, says HJI director Fatima Hassan

FDA approves injectable medication to be used as HIV prevention drug

The Food and Drug Administration (FDA) approved an injectable medication to be used as an HIV prevention drug on Wednesday.

FDA Approves Breakthrough HIV Drug, but It Could Be Hard to Access

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

Byanyima wants Trump to fund injectable Lenacapavir for PrEP

South Africa President Cyril Ramphosa with UNAIDS Executive Director, Winnie Byanyima. PHOTO URN Johannesberg, South Africa | THE INDEPENDENT | Food and Drug Administration (FDA) approval of injectable lenacapavir (LEN) for the prevention of HIV as pre-exposure prophylaxis (PrEP). LEN, developed by Gilead Sciences, is a twice-yearly injectable PrEP option that showed nearly complete protection against HIV in the landmark PURPOSE 1 and 2 trials. …